Analytecon SA

Switzerland

Back to Profile
1-2 of 2 for Analytecon SA Sort by
Query
Aggregations
IPC Class
A61K 31/472 - Non-condensed isoquinolines, e.g. papaverine 2
A61P 35/00 - Antineoplastic agents 2
C07D 217/20 - Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine 2
A61K 31/4738 - QuinolinesIsoquinolines ortho- or peri-condensed with heterocyclic ring systems 1
A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID] 1
See more
Found results for  patents

1.

ISOQUINOLINES AS IGF-1R INHIBITORS

      
Application Number IB2006002473
Publication Number 2007/029106
Status In Force
Filing Date 2006-09-08
Publication Date 2007-03-15
Owner ANALYTECON SA (Switzerland)
Inventor
  • Gunzinger, Jan
  • Leander, Kurt

Abstract

Compounds of the formula (I) were synthesized. They were found to down- regulate or inhibit the expression or function of the IGF-I receptor.

IPC Classes  ?

  • C07D 217/20 - Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
  • C07D 217/14 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
  • C07D 217/16 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
  • C07D 491/04 - Ortho-condensed systems
  • A61P 35/00 - Antineoplastic agents
  • A61K 31/472 - Non-condensed isoquinolines, e.g. papaverine
  • A61K 31/4738 - QuinolinesIsoquinolines ortho- or peri-condensed with heterocyclic ring systems

2.

ISOQUINOLINES DERIVATIVES AS IGF-1R INHIBITORS

      
Application Number IB2006002474
Publication Number 2007/029107
Status In Force
Filing Date 2006-09-08
Publication Date 2007-03-15
Owner ANALYTECON SA (Switzerland)
Inventor
  • Gunzinger, Jan
  • Leander, Kurt

Abstract

Compounds of the formula (I) were synthesized. They were found to down-regulate or inhibit the expression or function of the IGF-1 receptor.

IPC Classes  ?

  • C07D 217/18 - Aralkyl radicals
  • C07D 217/20 - Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
  • A61K 31/472 - Non-condensed isoquinolines, e.g. papaverine
  • A61P 35/00 - Antineoplastic agents
  • A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID]